1型糖尿病患者全身及肠道IgA免疫应答的改变
研究收集1型糖尿病患者(诊断1年内及超过1年)和健康对照者的粪便、口腔和血液样本,检测血清胰岛自身抗体、IgA结合细菌、表达IgA的B细胞及游离IgA水平。结果显示诊断1年内患者粪便IgA结合细菌比例高于健康对照,且与谷氨酸脱羧酶自身抗体滴度正相关;病程较长者IgA结合细菌水平高于诊断1年内者;1型糖尿病患者血清IgA浓度高于健康对照。结论认为1型糖尿病患者存在IgA免疫改变。
要点
- 诊断1年内的1型糖尿病患者粪便IgA结合细菌比例高于健康对照。
- 粪便IgA结合细菌比例与谷氨酸脱羧酶自身抗体滴度呈正相关。
- 1型糖尿病患者血清IgA浓度高于健康对照。
核心结论
- 1型糖尿病患者存在IgA免疫改变,尤其是粪便IgA结合细菌增加,可能参与β细胞自身免疫和疾病发展,并可能作为1型糖尿病治疗的新靶点。
研究设计与样本
- 收集1型糖尿病患者(诊断1年内及超过1年)和健康对照者的粪便、口腔和血液样本。
- 采用放射配体法检测血清胰岛自身抗体滴度,流式细胞术研究IgA结合细菌和表达IgA的B细胞,酶联免疫吸附试验测定口腔游离IgA水平,免疫比浊法测定血清和粪便游离IgA浓度。
主要发现
- 诊断1年内的1型糖尿病患者粪便IgA结合细菌比例高于健康对照者。
- 粪便IgA结合细菌比例与谷氨酸脱羧酶自身抗体滴度呈正相关。
- 病程较长的1型糖尿病患者IgA结合细菌水平高于诊断1年内者。
- 1型糖尿病患者血清IgA浓度高于健康对照者。
临床怎么用
- 作者认为1型糖尿病患者的IgA免疫改变可能作为治疗1型糖尿病的新靶点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Increasing evidence supports the observation that immunoglobulin A (IgA) exerts a critical effect on the susceptibility to autoimmunity by modulating gut homeostasis and subsequent host immunity. We hypothesized that the IgA immunity is altered in individuals with type 1 diabetes. To test our hypothesis, we investigated intestinal, oral, and peripheral IgA immune responses in individuals with type 1 diabetes. METHODS: We collected stool, oral cavity, and blood samples from participants diagnosed with type 1 diabetes (within 1 year and more than 1 year) and healthy control individuals. Serum islet autoantibody titers were detected by radioligand assays. IgA-bound bacteria and IgA-expressing B cells were studied by flow cytometry. Oral free IgA level was measured by enzyme-linked immunosorbent assay. Serum and stool free IgA concentrations were determined by immune-turbidimetry method. RESULTS: Individuals diagnosed with type 1 diabetes within 1 year had an increased proportion of stool IgA-bound bacteria compared with healthy control individuals. The proportion of stool IgA-bound bacteria was positively associated with glutamic acid decarboxylase autoantibody titer. Moreover, individuals with a longer disease duration displayed a higher level of IgA-bound bacteria than those diagnosed within 1 year. In contrast to healthy control individuals, type 1 diabetes patients had increased serum IgA concentrations. CONCLUSIONS: Individuals with type 1 diabetes display altered IgA immunity, especially increased stool IgA-bound bacteria, which is likely to contribute to β-cell autoimmunity and the disease development, and thus, might be considered as a novel therapeutic target for the treatment of type 1 diabetes.
引用
- Huang J, Huang G, Li X, et al. Altered Systemic and Intestinal IgA Immune Responses in Individuals With Type 1 Diabetes. J Clin Endocrinol Metab. 2020. PMID: 32860693. doi:10.1210/clinem/dgaa590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。